Bringing the fundamentals into focus…
Back to Aclaris Therapeutics, Inc.
How Aclaris Therapeutics, Inc. stacks up
ACRS · against 426 other Healthcare companies of similar size
Growth
5/ 100
Near the bottom of its peers.
Ranked #398 of 427 · scores higher than 6% of peers
Bars: peers in each 10-point band of the growth score55 peers with a growth score of 0–9, including ACRS · Click a bar to see the companies
Why growth scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 97% of peers. 3-year revenue growth: -35.9% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 96% of peers. Revenue growth: -51.0% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = ACRS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ACRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 441 reported | -51.0% | 3.1% | 4% | 33% | |
| Earnings per share growthHigher is better · 222 reported | Not reported | 3.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 418 reported | -35.9% | 3.1% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ACRS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 392 | 2.5B CNY (≈$346M) | 6 | 45 | |
| 398 | 5.2B CNY (≈$723M) | 5 | 9 | |
| 398 | 2.1B CNY (≈$290M) | 5 | 27 | |
| 398 | 7.4B HKD (≈$949M) | 5 | 49 | |
| 398 | 551M USD | 5 | 20 | |
| 398 | 952M USD | 5 | 3 | |
| 403 | 3.6B CNY (≈$506M) | 4 | 39 | |
| 403 | 6.0B CNY (≈$841M) | 4 | 29 | |
| 403 | 320M USD | 4 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score